Literature DB >> 16333549

Relationship between subjective and objective outcome measures after Heller myotomy and Dor fundoplication for achalasia.

S Gholoum1, L S Feldman, C G Andrew, S Bergman, S Demyttenaere, S Mayrand, D D Stanbridge, G M Fried.   

Abstract

BACKGROUND: The purpose of this study is to assess how subjective evaluation (heartburn, dysphagia, quality of life, and satisfaction) correlates with objective data after Heller myotomy and Dor fundoplication for achalasia.
METHODS: A total of 53 consecutive patients with achalasia undergoing laparoscopic Heller myotomy and Dor fundoplication were studied prospectively. Subjective evaluation was done preop and postop using the Gastroesophageal Reflux Disease Health-Related Quality of Life instrument (GERD-HRQL; 0 = best, 45 = worse), 4-point dysphagia and heartburn scales (0 = best, 3 = worst), patient satisfaction scale (0 = very satisfied, 5 = incapacitated), and the SF-12 general health-related quality-of-life score. At 3 months postop, patients were asked to undergo objective evaluation with 24-h pH testing, manometry, and endoscopy. Data are expressed as median (interquartile range) and analyzed by Wilcoxon signed rank test or Mann-Whitney U test.
RESULTS: Forty-nine patients were more than 3 months postsurgery. Comparing preop to postop, improvements were found in dysphagia [3 (2-3) to 0 (0-1)], heartburn [1 (0-2) to 0 (0-1)], GERD-HRQL [13.5 (6.3-22.5) to 2 (0-5)], satisfaction [3 (3-4) to 1 (0-1)], and SF-12 mental component summary [46 (37-56) to 58 (50-59)] and physical component summary [46 (36-53) to 55 (48-56)] scores (p < 0.0001 for all). Thirty-eight patients (78%) agreed to undergo objective testing, and complete data were available for 32 (65%). Four of 32 patients (12.5%) had evidence of reflux based on 24-h pH testing. Of nine patients with GERD-HRQL >5, only two had positive pH test (22%). Of 23 patients with GERD-HRQL <5, two had positive pH test (7%). Of four tested patients with moderate to severe heartburn, two had an abnormal pH test. There was no significant relationship between GERD-HRQL score and pH test results. Lower esophageal sphincter pressure (LESP) decreased from 24 (16-35) to 13 mmHg (11-17) (p < 0.001). There was no relationship between dysphagia score and postop absolute LESP or a decrease in LESP after operation.
CONCLUSIONS: Laparoscopic Heller myotomy and Dor fundoplication is an effective treatment for achalasia. Subjective evaluation can document patient satisfaction and health-related quality of life but does not accurately reflect postop reflux. Twenty-four-hour pH study is required to accurately assess reflux disease.

Entities:  

Mesh:

Year:  2005        PMID: 16333549     DOI: 10.1007/s00464-005-0213-7

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  23 in total

1.  The acid achalasia association.

Authors:  Morris Traube
Journal:  J Clin Gastroenterol       Date:  2002-04       Impact factor: 3.062

2.  Healing of duodenal ulcer with an antacid regimen.

Authors:  W L Peterson; R A Sturdevant; H D Frankl; C T Richardson; J I Isenberg; J D Elashoff; J Q Sones; R A Gross; R W McCallum; J S Fordtran
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

3.  Gastroesophageal reflux in achalasia. When is reflux really reflux?

Authors:  P F Crookes; S Corkill; T R DeMeester
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

4.  Quality of life scale for gastroesophageal reflux disease.

Authors:  V Velanovich; S R Vallance; J R Gusz; F V Tapia; M A Harkabus
Journal:  J Am Coll Surg       Date:  1996-09       Impact factor: 6.113

5.  Current status of an antireflux procedure in laparoscopic Heller myotomy.

Authors:  S Lyass; D Thoman; J P Steiner; E Phillips
Journal:  Surg Endosc       Date:  2003-02-17       Impact factor: 4.584

6.  Minimally invasive surgery for achalasia: an 8-year experience with 168 patients.

Authors:  M G Patti; C A Pellegrini; S Horgan; M Arcerito; P Omelanczuk; A Tamburini; U Diener; T R Eubanks; L W Way
Journal:  Ann Surg       Date:  1999-10       Impact factor: 12.969

7.  Prevalence of gastroesophageal reflux after laparoscopic Heller myotomy.

Authors:  W O Richards; R H Clements; P C Wang; C D Lind; H Mertz; J K Ladipo; M D Holzman; K W Sharp
Journal:  Surg Endosc       Date:  1999-10       Impact factor: 4.584

8.  Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective randomized double-blind clinical trial.

Authors:  William O Richards; Alfonso Torquati; Michael D Holzman; Leena Khaitan; Daniel Byrne; Rami Lutfi; Kenneth W Sharp
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

9.  Early results of laparoscopic Heller myotomy do not necessarily predict long-term outcome.

Authors:  Mark Bloomston; Alan Durkin; H Worth Boyce; Milton Johnson; Alexander S Rosemurgy
Journal:  Am J Surg       Date:  2004-03       Impact factor: 2.565

10.  Gastroesophageal reflux, quality of life, and satisfaction in patients with achalasia treated with open cardiomyotomy and partial fundoplication.

Authors:  Marta Ponce; Vicente Ortiz; Manuel Juan; Vicente Garrigues; Concepción Castellanos; Julio Ponce
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

View more
  13 in total

Review 1.  Recurrent achalasia treated with Heller myotomy: a review of the literature.

Authors:  Lan Wang; You-Ming Li
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

2.  Clinical outcomes five years after POEM for treatment of primary esophageal motility disorders.

Authors:  Ezra N Teitelbaum; Christy M Dunst; Kevin M Reavis; Ahmed M Sharata; Marc A Ward; Steven R DeMeester; Lee L Swanström
Journal:  Surg Endosc       Date:  2017-06-29       Impact factor: 4.584

3.  The International Per Oral Endoscopic Myotomy Survey (IPOEMS): a snapshot of the global POEM experience.

Authors:  Stavros N Stavropoulos; Rani J Modayil; David Friedel; Thomas Savides
Journal:  Surg Endosc       Date:  2013-04-03       Impact factor: 4.584

4.  Gastroesophageal reflux symptoms do not correlate with objective pH testing after peroral endoscopic myotomy.

Authors:  Edward L Jones; Michael P Meara; Jennifer S Schwartz; Jeffrey W Hazey; Kyle A Perry
Journal:  Surg Endosc       Date:  2015-06-27       Impact factor: 4.584

5.  Symptomatic outcome following laparoscopic Heller's cardiomyotomy with Dor fundoplication versus laparoscopic Heller's cardiomyotomy with angle of His accentuation: results of a randomized controlled trial.

Authors:  Pavithra Balakrishna; Rajinder Parshad; Jitender Rohila; Anoop Saraya; Govind Makharia; Raju Sharma
Journal:  Surg Endosc       Date:  2014-11-27       Impact factor: 4.584

Review 6.  Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature.

Authors:  Kristle L Lynch; John E Pandolfino; Colin W Howden; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

7.  Patterns of esophageal acid exposure after laparoscopic Heller's myotomy and Dor's fundoplication for esophageal achalasia.

Authors:  John Tsiaoussis; George Pechlivanides; Nikolaos Gouvas; Elias Athanasakis; Nikolaos Zervakis; Apostolos Manitides; Evaghelos Xynos
Journal:  Surg Endosc       Date:  2007-12-20       Impact factor: 4.584

8.  Efficacy and durability of robotic Heller myotomy for achalasia: patient symptoms and satisfaction at long-term follow-up.

Authors:  Kyle A Perry; Aliyah Kanji; Joseph M Drosdeck; John G Linn; Anthony Chan; Peter Muscarella; W Scott Melvin
Journal:  Surg Endosc       Date:  2014-05-31       Impact factor: 4.584

9.  Results of laparoscopic Heller myotomy without anti-reflux procedure in achalasia. Monocentric prospective study of 106 cases.

Authors:  M Robert; G Poncet; F Mion; J Boulez
Journal:  Surg Endosc       Date:  2007-10-18       Impact factor: 4.584

10.  Heller's myotomy and pneumatic dilatation in the treatment of achalasia: a population-based case-control study assessing long-term quality of life.

Authors:  R T Gray; H G Coleman; K W Lau; C McCaughey; P V Coyle; L J Murray; B T Johnston
Journal:  Dis Esophagus       Date:  2017-02-01       Impact factor: 3.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.